Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Theravance Biopharma, Inc. (TBPH)  
$9.49 0.05 (0.52%) as of 4:30 Wed 5/8


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 63,980,000
Market Cap: 607.17(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $8.22 - $11.59
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    : 18.6
Insider 6 Months    : 18.6
Insider 3/6 Months : 37.7
Guru Rank Number :  245
Guru Rank Value     : 4.8
Guru Occurances    : 2

 

            6 Months   1 Year   2 Year  
 
Company Profile   Theravance Biopharma is a biopharmaceutical company primarily focused on the discovery, development and commercialization of respiratory medicine medicines. Co.'s program include: YUPELRI™ (revefenacin) inhalation solution, nebulized long-acting muscarinic antagonist for the maintenance treatment of chronic obstructive pulmonary disease; and Lung-selective, Nebulized Pan-Janus Kinase (JAK) Inhibitor (Nezulcitinib), a lung-selective, nebulized JAK inhibitor, in clinical development for the potential treatment of hospitalized patients with acute lung injury caused by Coronavirus Disease 2019.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 1,499,124 1,499,124 1,499,124 1,499,124
Total Buy Value $13,117,335 $13,117,335 $13,117,335 $13,117,335
Total People Bought 1 1 1 1
Total Buy Transactions 1 1 1 1
Total Shares Sold 1,254 5,114 22,963 172,089
Total Sell Value $10,922 $50,468 $231,475 $1,835,193
Total People Sold 1 2 2 4
Total Sell Transactions 1 3 11 21
End Date 2024-02-08 2023-11-07 2023-05-09 2022-05-09

   
Records found: 530
  Page 17 of 22  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Hegde Sharathchandra S SVP, Research   •       –      –    2017-02-20 4 D $33.78 $342,462 D/D (10,138) 170,490     -
   Pitzer Kenneth R SVP, Prod Strat & Comm Plng   •       –      –    2017-02-20 4 D $33.78 $338,813 D/D (10,030) 162,347     -
   Gala Renee D SVP, Chief Financial Officer   •       –      –    2017-02-20 4 D $33.78 $344,928 D/D (10,211) 226,350     -
   Haumann Brett K SVP Clin Dev & Chief Med Ofc   •       –      –    2017-02-20 4 D $33.78 $487,581 D/D (14,434) 177,471     -
   Winningham Rick E Chief Executive Officer   •       •      –    2017-02-20 4 D $33.78 $1,123,658 D/D (33,264) 870,135     -
   Pasqualone Frank SVP Global Head Acute Care Bus   •       –      –    2017-02-20 4 D $33.78 $295,980 D/D (8,762) 219,118     -
   Winningham Rick E Chief Executive Officer   •       •      –    2017-02-06 4 A $0.00 $0 D/D 28,000 903,399     -
   Worboys Philip D SVP, Translational Science   •       –      –    2017-02-06 4 A $0.00 $0 D/D 9,000 184,332     -
   Haumann Brett K SVP Clin Dev & Chief Med Ofc   •       –      –    2017-02-06 4 A $0.00 $0 D/D 9,000 191,905     -
   Hegde Sharathchandra S SVP, Research   •       –      –    2017-02-06 4 A $0.00 $0 D/D 9,000 180,628     -
   Shafer Bradford J EVP, Gen. Counsel, Secretary   •       –      –    2017-02-06 4 A $0.00 $0 D/D 9,000 200,722     -
   Gala Renee D SVP, Chief Financial Officer   •       –      –    2017-02-06 4 A $0.00 $0 D/D 9,000 236,561     -
   Pasqualone Frank SVP Global Head Acute Care Bus   •       –      –    2017-02-06 4 A $0.00 $0 D/D 9,000 227,880     -
   Pitzer Kenneth R SVP, Prod Strat & Comm Plng   •       –      –    2017-02-06 4 A $0.00 $0 D/D 9,000 172,377     -
   Worboys Philip D SVP, Translational Science   •       –      –    2016-11-20 4 D $31.96 $67,244 D/D (2,104) 175,332     -
   Winningham Rick E Chief Executive Officer   •       •      –    2016-11-20 4 D $31.96 $267,186 D/D (8,360) 875,399     -
   Shafer Bradford J EVP, Gen. Counsel, Secretary   •       –      –    2016-11-20 4 D $31.96 $128,096 D/D (4,008) 191,722     -
   Hegde Sharathchandra S SVP, Research   •       –      –    2016-11-20 4 D $31.96 $58,966 D/D (1,845) 171,628     -
   Haumann Brett K SVP Clin Dev & Chief Med Ofc   •       –      –    2016-11-20 4 D $31.96 $172,200 D/D (5,388) 182,905     -
   Lee Junning Sr. VP, Technical Operations   •       –      –    2016-11-20 4 D $31.96 $120,969 D/D (3,785) 234,682     -
   Pitzer Kenneth R SVP, Prod Strat & Comm Plng   •       –      –    2016-11-20 4 D $31.96 $55,195 D/D (1,727) 163,377     -
   Gala Renee D SVP, Chief Financial Officer   •       –      –    2016-11-20 4 D $31.96 $147,911 D/D (4,628) 227,561     -
   Haumann Brett K SVP Clin Dev & Chief Med Ofc   •       –      –    2016-08-25 4 S $27.99 $125,703 D/D (4,491) 188,293     -
   Shafer Bradford J EVP, Gen. Counsel, Secretary   •       –      –    2016-08-22 4 S $27.16 $1,007,038 D/D (37,078) 195,730     -
   Pitzer Kenneth R SVP, Prod Strat & Comm Plng   •       –      –    2016-08-20 4 D $27.89 $48,222 D/D (1,729) 165,104     -
  530 Records found
  Previous  10  11  12  13  14  15  16  17  18  19  Next   
  Page 17 of 22
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us